![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Pronóstico del mercado de inmunohistoquímica de América del Sur hasta 2028: impacto de COVID-19 y análisis regional por aplicación (diagnóstico y pruebas de fármacos), producto (anticuerpos, equipos, reactivos y kits) y usuario final (hospitales y laboratorios de diagnóstico, institutos de investigación y otros) )
Introducción al mercado
Los principales países incluidos como parte del análisis para SAM incluyen Argentina, Brasil y el resto de SAM. Brasil lideró el mercado en 2021. Brasil es la economía más grande de América Latina y su sector de salud se distribuye entre sectores públicos y privados. La fabricación local se limita a consumibles y artículos ordinarios, y hay pocos fabricantes de dispositivos de alta tecnología. Por lo tanto, Brasil importa muchos dispositivos médicos de otros países. El cáncer es una de las principales enfermedades epidémicas y el número de personas diagnosticadas con cáncer se ha duplicado en las últimas tres décadas. Según datos presentados en un artículo de la Revista Brasileira de Cancerologia 2018, durante 2018-2019, habría ~600.000 nuevos casos de cáncer en el país. Según el informe de VanEck Research publicado en 2017, el mercado de diagnóstico en Brasil está creciendo. Hay alrededor de 22.000 laboratorios repartidos por todo Brasil. Los cuatro principales actores del mercado son los cuatro principales participantes del mercado; Diagnósticos da América SA (DASA), Fleury SA, Centro de Imagem Diagnósticos SA (Alliar) e Instituto Hermes Pardini SA (Hermes Pardini). El factor clave para el crecimiento del mercado de diagnóstico es el envejecimiento de la población. El informe también menciona que el 52% de la población total tendrá 45 años o más para 2050. Según los factores mencionados anteriormente, es probable que Brasil ofrezca varias oportunidades de crecimiento para los actores del mercado de inmunohistoquímica durante el período de pronóstico.
Los países de la Región SAM, especialmente Brasil, se encuentran muy afectados por el brote de COVID-19. El brote ha afectado gravemente a los servicios médicos de la región. Los países también son famosos por el turismo médico, que también se ve afectado por la pandemia. Brasil, Argentina, Uruguay, Chile, Perú y Colombia se ven afectados por la segunda ola del brote de COVID-19. Según Worldometer, al 3 de septiembre de 2021, Brasil reportó 558.597 víctimas y 21 millones de nuevos casos de COVID-19. Hubo 5,2 millones de casos nuevos en Argentina, una señal de la segunda ola del brote de COVID-19. Se prevé que SAM impondrá un segundo bloqueo, lo que eventualmente obstaculizará la industria de la salud en la región. Brasil, Argentina, Uruguay, Chile, Perú y Colombia están preocupados por la segunda ola. Entre los cuales Brasil ha registrado la mayoría de las muertes.
Descripción general y dinámica del mercado
Se espera que el mercado de inmunohistoquímica SAM crecer de US$ 129,48 millones en 2021 a US$ 202,68 millones en 2028; se estima que crecerá a una tasa compuesta anual del 6,6% de 2021 a 2028. La inmunohistoquímica (IHC) se refiere a una aplicación importante de anticuerpos monoclonales y policlonales para la determinación tisular y la distribución de antígenos de una enfermedad particular. Se utiliza principalmente para detectar varios trastornos infecciosos como el dengue, la hepatitis y el virus de la inmunodeficiencia humana (VIH). Las afecciones médicas crónicas como la obesidad, el cáncer, la diabetes, las enfermedades cardíacas y los accidentes cerebrovasculares también se consideran las principales aplicaciones de la inmunohistoquímica que ayudan en el diagnóstico de estas enfermedades. La diabetes prevalece a un ritmo elevado entre la población geriátrica de toda la región. La prevalencia de diabetes es mayor en personas con sobrepeso y obesidad. Las tasas de obesidad han aumentado rápidamente en las economías desarrolladas y en desarrollo de toda la región. Factores como el estilo de vida poco saludable y el sedentarismo se encuentran entre los principales responsables del aumento del número de personas obesas. Las enfermedades cardiovasculares (ECV) incluyen enfermedades cerebrovasculares, enfermedades cardíacas reumáticas, enfermedades coronarias y otras afecciones. Es la causa más importante de morbilidad y mortalidad en toda la región. Además, ha habido un aumento en las tasas de incidencia y mortalidad del cáncer en toda la región, lo que convierte al cáncer en la principal causa de muerte. Se espera que tal aumento en la incidencia de enfermedades crónicas e infecciosas cree una demanda de pruebas de inmunoensayo en la región SAM.
Segmentos clave del mercado
En términos de producto, el segmento de anticuerpos representó la mayor participación del mercado de inmunohistoquímica SAM en 2020. En términos de aplicación, el segmento de diagnóstico tuvo una mayor participación de mercado en el mercado de inmunohistoquímica SAM en 2020. Además, el segmento de hospitales y laboratorios de diagnóstico tuvo una mayor participación en el mercado de inmunohistoquímica SAM según el usuario final en 2020.
Principales fuentes y empresas incluidas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de inmunohistoquímica SAM son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Abcam plc; Tecnologías Agilent, Inc.; Bio SB; LABORATORIOS BIO-RAD INC.; Danaher; F. HOFFMANN-LA ROCHE LTD.; MERCK KGaA; PerkinElmer Inc.; y THERMO FISHER SCIENTIFIC INC.
Informe de razones para comprar
< ul>Segmentación del mercado de inmunohistoquímica SAM
Mercado de inmunohistoquímica SAM - Por producto
- Equipo
- Sistemas de tinción de portaobjetos
- Sistemas de microarrays de tejidos
- Procesamiento de tejidos Sistemas
- Escáneres de diapositivas
- Otros equipos
- Anticuerpos
- Anticuerpos primarios
- Anticuerpos secundarios
- Reactivos
- Tinciones histológicas
- Reactivos de bloqueo y fijación
- Sustratos cromogénicos
- Reactivos de fijación
- Estabilizadores
- Disolventes orgánicos
- Enzimas proteolíticas
- Diluyentes
- Kits
Mercado de inmunohistoquímica SAM - Por aplicación
- Diagnóstico
- Cáncer
- Enfermedades infecciosas
- Enfermedades autoinmunes
- Diabetes mellitus
- Enfermedades nefrológicas
- Otras
- Pruebas de fármacos
Mercado de inmunohistoquímica SAM - Por usuario final
- Hospitales y laboratorios de diagnóstico
- Institutos de investigación
- Otros
Mercado de inmunohistoquímica SAM: por país
- Brasil
- Argentina
- Resto de SAM
Mercado de Inmunohistoquímica de SAM: perfiles de empresas
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Immunohistochemistry Market – By Product
1.3.2 SAM Immunohistochemistry Market – By Application
1.3.3 SAM Immunohistochemistry Market – By End User
1.3.4 SAM Immunohistochemistry Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Immunohistochemistry Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Immunohistochemistry Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing R&D Investments by Biotechnology & Biopharmaceutical Companies
5.2 Key Market Restraints
5.2.1 Limitations Associated with Immunohistochemistry
5.3 Key Market Opportunities
5.3.1 Development Opportunities in Emerging Countries
5.4 Future Trends
5.4.1 Increasing Acceptance of Automation in Immunohistochemistry
5.5 Impact Analysis
6. Immunohistochemistry Market – SAM Analysis
6.1 SAM Immunohistochemistry Market Revenue Forecast and Analysis
7. SAM Immunohistochemistry Market Analysis– By Product
7.1 Overview
7.2 SAM Immunohistochemistry Market, By Product 2021 & 2028 (%)
7.3 Antibodies
7.3.1 Overview
7.3.2 Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.3 Primary Antibodies
7.3.3.1 Overview
7.3.3.2 Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.4 Secondary Antibodies
7.3.4.1 Overview
7.3.4.2 Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Equipment Market
7.4.1 Overview
7.4.2 Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 Slide Staining Systems
7.4.3.1 Overview
7.4.3.2 Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Tissue Microarrays
7.4.4.1 Overview
7.4.4.2 Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Tissue Processing Systems
7.4.5.1 Overview
7.4.5.2 Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Slide Scanners
7.4.6.1 Overview
7.4.6.2 Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Other Equipments
7.4.7.1 Overview
7.4.7.2 Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Reagents Market
7.5.1 Overview
7.5.2 Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.3 Histological Stains
7.5.3.1 Overview
7.5.3.2 Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.4 Blocking Sera & Reagents Market
7.5.4.1 Overview
7.5.4.2 Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.5 Chromogenic Substrates Market
7.5.5.1 Overview
7.5.5.2 Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.6 Stabilizers
7.5.6.1 Overview
7.5.6.2 Stabilizers Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.7 Proteolytic Enzymes
7.5.7.1 Overview
7.5.7.2 Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.8 Organic Solvents
7.5.8.1 Overview
7.5.8.2 Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.9 Fixation Reagents
7.5.9.1 Overview
7.5.9.2 Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.5.10 Diluents
7.5.10.1 Overview
7.5.10.2 Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Kits Market
7.6.1 Overview
7.6.2 Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
8. SAM Immunohistochemistry Market Analysis – By Application
8.1 Overview
8.2 SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)
8.3 Diagnostics
8.3.1 Overview
8.3.2 Diagnostics Market Revenue and Forecast to 2028 (US$ Mn)
8.3.3 Cancer
8.3.3.1 Overview
8.3.3.2 Cancer Market Revenue and Forecast to 2028 (US$ Mn)
8.3.4 Infectious Diseases
8.3.4.1 Overview
8.3.4.2 Infectious Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.5 Autoimmune Diseases
8.3.5.1 Overview
8.3.5.2 Autoimmune Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.6 Diabetes Mellitus
8.3.6.1 Overview
8.3.6.2 Diabetes Mellitus Market Revenue and Forecast to 2028 (US$ Mn)
8.3.7 Nephrological Diseases
8.3.7.1 Overview
8.3.7.2 Nephrological Diseases Market Revenue and Forecast to 2028 (US$ Mn)
8.3.8 Others
8.3.8.1 Overview
8.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Drug Testing
8.4.1 Overview
8.4.2 Drug Testing Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM Immunohistochemistry Market Analysis– By End User
9.1 Overview
9.2 SAM Immunohistochemistry Market, By End User 2021 & 2028 (%)
9.3 Hospital & Diagnostic Laboratories
9.3.1 Overview
9.3.2 Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Research Institutes
9.4.1 Overview
9.4.2 Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Others
9.5.1 Overview
9.5.2 Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10. SAM Immunohistochemistry Market – Country Analysis
10.1 SAM Immunohistochemistry Market Revenue and Forecasts To 2028
10.1.1 SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
10.1.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.1 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.1.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.1.2.1 Argentina Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.1.2.2 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.1.2.3 Argentina Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.1.3 Argentina Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.1.3.1 Argentina Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.1.4 Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.1 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
10.1.1.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.2.2.1 Brazil Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.2.2.2 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.2.2.3 Brazil Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.2.3 Brazil Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.2.3.1 Brazil Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.2.4 Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.1.1.3 Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.1 Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
10.1.1.3.2 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.1.1.3.2.1 Rest of SAM Diagnostics Market Revenue and Forecasts To 2028, By Equipments (US$ Mn)
10.1.1.3.2.2 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
10.1.1.3.2.3 Rest of SAM Antibodies Market Revenue and Forecasts To 2028, By Reagents (US$ Mn)
10.1.1.3.3 Rest of SAM Equipment Market Revenue and Forecasts To 2028, By Application (US$ Mn)
10.1.1.3.3.1 Rest of SAM Reagents Market Revenue and Forecasts To 2028, By Diagnostics (US$ Mn)
10.1.1.3.4 Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
11. Impact Of COVID-19 Pandemic on SAM Immunohistochemistry Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic developments
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 PerkinElmer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 THERMO FISHER SCIENTIFIC INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Abcam plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Agilent Technologies, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BIO-RAD LABORATORIES INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Danaher
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bio SB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. SAM Immunohistochemistry Market – Revenue and Forecast to 2028 (USD Million)
Table 2. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 3. Argentina Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 4. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 5. Argentina Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 6. Argentina Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 7. Argentina Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 8. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 9. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 10. Brazil Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 11. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 12. Brazil Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 13. Brazil Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 14. Brazil Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 15. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 16. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 17. Rest of SAM Diagnostics Market Revenue and Forecasts to 2028, By Equipments (US$ Mn)
Table 18. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Antibodies (US$ Mn)
Table 19. Rest of SAM Antibodies Market Revenue and Forecasts to 2028, By Reagents (US$ Mn)
Table 20. Rest of SAM Equipment Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 21. Rest of SAM Reagents Market Revenue and Forecasts to 2028, By Diagnostics (US$ Mn)
Table 22. Rest of SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 23. Organic Developments Done By Companies
Table 24. Inorganic developments done by Companies
Table 25. Glossary of Terms
LIST OF FIGURES
Figure 1. SAM Immunohistochemistry Market Segmentation
Figure 2. SAM Immunohistochemistry Market Segmentation, By Country
Figure 3. SAM Immunohistochemistry Market Overview
Figure 4. Antibodies Segment Held the Largest Share of the Market in 2021
Figure 5. Brazil to Show Significant Growth During Forecast Period
Figure 6. SAM PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to SAM Immunohistochemistry Market
Figure 8. SAM Immunohistochemistry Market – Revenue Forecast and Analysis
Figure 9. SAM Immunohistochemistry Market, by Product 2021 & 2028 (%)
Figure 10. SAM Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. SAM Primary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM Secondary Antibodies: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Equipment: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Slide Staining Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. SAM Tissue Microarrays: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. SAM Tissue Processing Systems: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Slide Scanners: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. SAM Other Equipments: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. SAM Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. SAM Histological Stains: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. SAM Blocking Sera & Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. SAM Chromogenic Substrates: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. SAM Stabilizer: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. SAM Proteolytic Enzymes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. SAM Organic Solvents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. SAM Fixation Reagents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. SAM Diluents: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. SAM Kits: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 29. SAM Immunohistochemistry Market Share by Application 2021 & 2028 (%)
Figure 30. SAM Diagnostics Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. SAM Cancer Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. SAM Infectious Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. SAM Autoimmune Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 34. SAM Diabetes mellitus Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. SAM Nephrological Diseases Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. SAM Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. SAM Drug Testing Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 38. SAM Immunohistochemistry Market, by End User 2021 & 2028 (%)
Figure 39. SAM Hospital & Diagnostic Laboratories: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. SAM Research Institutes: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 41. SAM Others: Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 42. SAM Immunohistochemistry Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 43. SAM Immunohistochemistry Market Revenue and Forecasts to 2028, By Country (%)
Figure 44. Argentina Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 45. Brazil Immunohistochemistry Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 46. Rest of SAM: Immunohistochemistry Market– Revenue and Forecast to 2028 (USD Mn)
Figure 47. Impact Of COVID-19 Pandemic in SAM Country Markets
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM immunohistochemistry market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM immunohistochemistry market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the immunohistochemistry market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution